India US energy war Courtesy: MEA India / Flickr
9 December 2015

COP21: unspoken India-U.S. war

An unspoken war has been waged between India and the U.S. at the COP21 Summit in Paris. If the West wants India to opt for more expensive energy options, then they must also reciprocate by sharing technology.

IAFS MEA Courtesy: MEA
5 November 2015

Can India allay Africa’s IPR fears?

The U.S. is urging India to alter its IPR regime, and the potential impact on prices in the pharmaceuticals sector is of concern to African countries that depend on India for low-cost generic medicines. The recent India-Africa Forum Summit in New Delhi sought to address this issue, but it will be a challenge for India to balance competing pressures.

Pharma Pixelbay Courtesy: Pixabay
21 October 2015

Will the TPP impact Indian pharma?

Do the TPP and the proposed India-EU trade deal extend protection of IPR, delaying generic competition for life-saving drugs and keeping their prices high? While these and other possible implications for Indian consumers and pharma companies become clearer over time, India must robustly engage with the debate on trade deals and public interest

Leaders_of_TPP_member_states- wikipedia Courtesy: Wikipedia
20 May 2015

TPP and RCEP: the hare and the tortoise?

The Trans-Pacific Partnership might soon be concluded if the U.S. Congress fast-tracks it, as recently announced, while the Regional Comprehensive Economic Partnership Agreement remains on slow-track. But the TPP, although ambitious, follows an outdated template, and it is the dynamic RCEP that can be a model for a new global rules-based framework

Modi & Obama Courtesy: MEA Flickr
15 January 2015

What Modi-Obama can achieve together

During President Obama’s visit to India to attend the Republic Day parade, if he and Prime Minister Modi announce specific agreements related to the two most vibrant components of the relationship—defence and technology—it will pave the way for real progress on the September 2014 US-India joint statement.

narendra sabharwal Courtesy: Rajeshwari Krishnamurthy/Gateway House
6 June 2013

IPR: ‘Developing countries need to be cautious’

The Indian Supreme Court’s verdict in the Novartis case over patent rights has opened up the debate on intellectual property rights (IPR) in India, and globally. Gateway House interviews Narendra Sabharwal, Chair, IPR Committee, FICCI, to discuss the role of IPR and public health concerns in emerging economies.

Americas Quarterly_1 Courtesy: Americas Quarterly
20 August 2012

India-Peru: New Pacific Pivot

Americas Quarterly republished Gateway House's Hari Seshasayee's article on India-Peru relations. He argues that new commercial exchanges between the two can enhance the bilateral, but strategic elements must be incorporated if both countries are to benefit from each others' geopolitical alliances.

peru india Courtesy: Indian Council of World Affairs
12 July 2012

India-Peru: A new Pacific pivot

The Indian Council of World Affairs republished Gateway House's Hari Seshasayee's feature on the India-Peru relationship. He argues that new commercial exchanges can enhance the bilateral, but strategic elements must be incorporated if both countries are to benefit from each others' geopolitical alliances.

Pyzhou_3x2 Courtesy: Pyzhou
28 September 2010

China’s Innovation Wall

In a bid to end its dependence on foreign intellectual property and become a global power in science and technology, China is attempting to foster indigenous innovation. Are the U.S. government and business community right to be worried about threats to free trade and intellectual property rights?